The Recall Desk
Agency classClass IOur severity:SevereFDA (Devices)·Z-0309-2017·Announced 2016-11-16

Ev3 Neurovascular Recalls Marathon and UltraFlow Micro Catheters

Micro Therapeutics Inc. is recalling Marathon and UltraFlow HPC Flow Directed Micro Catheters because PTFE coating may delaminate and enter the bloodstream.

The agency’s classification

FDA (Devices): Class I

Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 4/5 (Severe).

The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The agency classified this recall as Class I — a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death. On that classification alone this is scored Severe; a score of Critical is reserved for recalls where a death or serious injury was reported. The agency gives the reason as: "Delamination and detachment of the PTFE (polytetrafluoroethylene) coating material may lead to PTFE coating in the blood stream."

Plain-English summary

Micro Therapeutics Inc., doing business as Ev3 Neurovascular, is recalling Marathon Flow Directed Micro Catheters and UltraFlow HPC Flow Directed Micro Catheters. The recall involves 66,429 units distributed worldwide, including the United States and numerous international markets.

The recall is due to a potential defect where the PTFE (polytetrafluoroethylene) coating material may delaminate and detach. This could lead to PTFE coating material entering the patient's bloodstream. The devices are intended for accessing peripheral and neurovasculature for the controlled selective infusion of therapeutic agents, such as embolization materials, and diagnostic materials, such as contrast media.

Healthcare providers and patients should check their inventory and patient records for the affected catalog numbers and lot codes listed in the official recall notice. If you have used these devices, contact your healthcare provider for guidance.

The recalled product

Product
Marathon Flow Directed Micro Catheter, UltraFlow HPC Flow Directed Micro Catheter Marathon Flow: The device is intended to access periphera and neurovasculature for the controlled selective infusion of physician-specified therapeutics agents such as embolization materials and…
Affected units
66,429

Distribution

Distributed nationwide across the United States.

The notice also names 1 state specifically:

Part of a larger recall action

This product is one of 4 recalled by Micro Therapeutics Inc, Dba Ev3 Neurovascular under a single FDA (Devices) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 4 products in this recall →

Similar recalls